Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIR fluorescence-guided neck dissection with peritumoral indocyanine green in head and neck cancer
2014-000298-37Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in head and neck cancer (HNC), sponsored by Institut Jules Bordet. Primary endpoint: Intraoperative feasibility of ICG-based NIR lymph node imaging. Started Sep 2014; status: completed.
02
Drugs
indocyanine green
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on 2014-000298-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000298-37.